Canton Strategic Holdings Inc
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Mark Wendland
- Full Time Employees
- 12
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 34 Shrewsbury Avenue Red Bank NJ United States of America 07701
- IPO Date
- Jan 12, 2022
- CIK
- 0001861657
- Website
- cantonstrategic.com
- Similar Companies
- Business
- Canton Strategic Holdings Inc. engages in Canton Network-related activities and biotechnology development, combining digital-asset infrastructure initiatives with clinical-stage biotech research and development. The company focuses on leveraging Canton Coin to support blockchain-based financial market digitization, operates validator nodes to facilitate network security and governance, and pursues a diversified biotechnology pipeline led by GV104 and GV023 for specialty therapeutic indications. Canton Strategic Holdings also pursues strategic investments and partnerships to advance institutional adoption of the Canton Network, including participation in network governance through board roles and ecosystem collaborations. The company was founded in 2017 and is headquartered in Frankfurt am Main, with its primary listing and public disclosures centered in the United States and international market channels. Subsidiaries and affiliates span technology infrastructure operations tied to Canton Network services and biotechnology development platforms, positioning the firm as a multi-industry holding with a core emphasis on digital asset infrastructure, network governance, and targeted biopharmaceutical innovation. As of its latest developments, the company completes major financing rounds to expand Canton-centric digital-asset treasury activities, broadens its validator footprint to support increasing daily transaction volumes, and strengthens governance participation through board appointments and strategic alliances. The近-term strategy emphasizes accelerating network momentum, expanding capital capacity, and advancing targeted therapeutic programs, while maintaining a focus on long-term shareholder value through diversified operating assets and strategic partnerships.
Company News
Canton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial and Operational Results
Canton Strategic: Highly Intriguing Blockchain Treasury With Tangible Risks
Three New Directors Elected to the Board of Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLC
Canton Strategic Holdings, Inc. Delivers Second Quarter Canton Network Ecosystem Update
Canton Strategic Holdings, Inc. Announces Launch of Locking Service to Support Network Infrastructure Providers
Canton Strategic Holdings, Inc. Expected to Be Included in Russell 3000® and Russell 2000®
Canton Strategic Holdings, Inc. Announces Authorization of Share Repurchase Program
Canton Strategic Holdings Reports First Quarter 2026 Financial and Operational Results
Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Update
Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results
BitGo to Securely Store Digital Asset Treasury Holdings for Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. Chairman and CEO Mark Wendland Elected to Canton Foundation Board